A Study Testing the Safety and Effects of Single Doses of S1-221 in Healthy Volunteers

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 30, 2025

Primary Completion Date

February 22, 2026

Study Completion Date

February 28, 2026

Conditions

Healthy Participants

Interventions

DRUG

S1-221

S1-221 will be administered orally to participants.

DRUG

Placebo

Matching placebo will be administered orally to participants.

DRUG

THC

A single dose of THC will be administered to participants orally.

Trial Locations (1)

Nucleus Network, Melbourne

All Listed Sponsors

lead

Delphian Therapeutics Australia Pty, Ltd

INDUSTRY